Global Resonance Technologies, LLC
Reducing radiation morbidity and mortality through technology.
Who We Are
Global Resonance Technologies, LLC (GRT) is a privately-held medical technology innovation and development company. GRT creates high-quality, effective, and affordable dosimetry technology and systems for nuclear disaster and radiation emergency preparedness and response efforts around the world.
In partnership with the United States government and industry partners, GRT is developing the Emergency Response Dosimetry System (ERDS). ERDS is currently in the advanced stages of development and testing.
The primary application of the Emergency Response Dosimetry System (ERDS) is to rapidly sort survivors after a nuclear disaster or radiation incident. ERDS will also enable long-term radiation exposure research and monitoring and modernize industrial radiation sterilization processes.
Due to the lack of individual-level, omnipresent testing technology, known or suspected population-scale radiation exposure is the most challenging emergency facing health and security planners and responders.
The ability to identify casualties at risk for Acute Radiation Syndrome (ARS) after ionizing radiation exposure is crucial to the prompt administration of lifesaving medical care and countermeasures. Equally important is the rapid identification of non- or minimally exposed victims to support strategic response planning and resource management.
The critical first steps after such an incident are the protection of first responders and efficient population sorting by exposure. This requires physical dosimetry technology that is accurate, quick, and accessible for widespread deployment.
ERDS will fill this critical gap in responding to a catastrophic nuclear disaster or radiological event by providing an effective means of sorting patients at risk for Acute Radiation Syndrome (ARS).